Crohn Disease (CD)

the REMONO-CD and the REMONO-UC Studies

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

HB-adMSCs for the Treatment of Crohn's Disease

Study of Concordance Between Inflammatory Activity Assessed by Enteric MRI With and Without Intestinal Distension Product in Patients With Ileal Crohn's Disease.

Qualitative Exploration of Key Symptoms of Stricturing Crohn's Disease: Toward the Development of a Clinical Assessment Score.

Evaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease

Health-Related Quality of Life Among Patients With Inflammatory Bowel Disease

Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions

Safety and Efficiency of the Universal CNK-UT009 in Difficult-to-treat Inflammatory Bowel Disease Patients

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease

Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study

Fluorescence Imaging of Adalimumab-680LT and Risankizumab-800CW in Inflammatory Bowel Disease

Exploring Multiple Self-Help Interventions to Promote Self-Efficacy and Overcome Disability

CEDUR - German IBD Registry

Prospective Risk Evaluation and Detection of Crohn's Disease in First-degree Relatives

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis